التفاصيل البيبلوغرافية
| العنوان: |
Supplementary Figure 2 from CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma |
| المؤلفون: |
Ghassan K. Abou-Alfa, Susan M. Geyer, Andrew B. Nixon, Federico Innocenti, Qian Shi, Priya Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H. Schwartz, Anthony B. El-Khoueiry, Jennifer J. Knox, Lakshmi Rajdev, Monica M. Bertagnolli, Jeffrey A. Meyerhardt, Eileen M. O'Reilly, Alan P. Venook |
| سنة النشر: |
2024 |
| مصطلحات موضوعية: |
Cancer, Therapeutic Research and Development, Clinical Research and Trials, Gastrointestinal Cancers, Liver cancer, Translational Research, Small Molecule Agents, Kinase inhibitors, Topoisomerase agents, DNA-reactive agents, Chemotherapy, Combination chemotherapy, Clinical-Stage Research, Clinical Trial Results, Phase III clinical trials |
| الوصف: |
Supplementary Figure 2. Tile plots of HCV viral ჼ00ter levels over ჼ00me for paჼ00ents treated with Doxorubicin and Sorafenib (A) or Sorafenib alone (B). For sample collected at the progression ჼ00me point, the ჼ00ming of progression is reflected as text in that ჼ00le. |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
unknown |
| العلاقة: |
https://figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_CALGB_80802_Alliance_Impact_of_Sorafenib_with_and_without_Doxorubicin_on_Hepatitis_C_Infection_in_Patients_with_Advanced_Hepatocellular_Carcinoma/25359915Test |
| DOI: |
10.1158/2767-9764.25359915.v1 |
| الإتاحة: |
https://doi.org/10.1158/2767-9764.25359915.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_CALGB_80802_Alliance_Impact_of_Sorafenib_with_and_without_Doxorubicin_on_Hepatitis_C_Infection_in_Patients_with_Advanced_Hepatocellular_Carcinoma/25359915Test |
| حقوق: |
CC BY |
| رقم الانضمام: |
edsbas.8F21C255 |
| قاعدة البيانات: |
BASE |
